Cafergot

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Osta kohe

Infovoldik Infovoldik (PIL)
19-04-2020
Toote omadused Toote omadused (SPC)
19-04-2020

Toimeaine:

Caffeine 100mg (anhydrous); Ergotamine tartrate 1mg;  ;  

Saadav alates:

AFT Pharmaceuticals Ltd

INN (Rahvusvaheline Nimetus):

Caffeine 100 mg (anhydrous)

Annus:

100 mg/1 mg

Ravimvorm:

Tablet

Koostis:

Active: Caffeine 100mg (anhydrous) Ergotamine tartrate 1mg     Excipient: Iron oxide yellow Magnesium stearate Microcrystalline cellulose Purified talc Starch Tartaric acid

Ühikuid pakis:

Bottle, glass, 100-tablet amber glass, 100 tablets

Klass:

Prescription

Retsepti tüüp:

Prescription

Valmistatud:

Siegfried PharmaChemikalien Minden GmbH

Näidustused:

Treatment of acute attacks of migraine with or without aura in adults.

Toote kokkuvõte:

Package - Contents - Shelf Life: Bottle, glass, Amber glass - 100 tablets - 24 months from date of manufacture stored at or below 25°C

Loa andmise kuupäev:

1969-12-31

Infovoldik

                                CAFERGOT
ERGOTAMINE TARTRATE 1 MG AND CAFFEINE 100 MG TABLETS
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully before you start taking Cafergot.
This leaflet answers some common questions about Cafergot tablets
It does not contain all the available information. It does not take
the place of talking to
your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you
using Cafergot against the benefits it can provide.
IF YOU HAVE ANY CONCERNS ABOUT CAFERGOT, ASK YOUR DOCTOR OR
PHARMACIST. KEEP THIS
LEAFLET WITH THE MEDICINE. You may need to read it again.
WHAT CAFERGOT IS USED FOR
CAFERGOT IS USED TO TREAT ATTACKS OF MIGRAINE WITH OR WITHOUT AURA.
These headaches are thought to be caused by temporary changes in the
size of small
blood vessels in the brain. These blood vessels swell, causing the
pain and visual
disturbances that often happen during an attack. Cafergot stops the
attack by causing
the blood vessels to constrict (shrink) back to normal size.
Cafergot is only taken to treat migraine attacks. It is not taken to
prevent attacks from
happening.
There are some types of headaches which must not be treated with
Cafergot. Your
doctor will determine the best treatment for your headache.
Cafergot tablets contain the active ingredients, ergotamine tartrate
and caffeine.
Ergotamine belongs to a group of medicines known as the "ergot
alkaloids." Caffeine
helps ergotamine work better and faster by increasing its absorption
into the body.
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY CAFERGOT HAS BEEN
PRESCRIBED
FOR YOU.
Your doctor may have prescribed Cafergot for another reason.
Cafergot is only available with a doctor's prescription.
There is not enough information to recommend this medicine for
children under 6 years
of age.
BEFORE YOU TAKE CAFERGOT
_WHEN YOU MUST NOT TAKE CAFERGOT_
_ _
DO NOT TAKE CAFERGOT IF YOU HAVE EVER HAD AN ALLERGIC REACTION TO ANY
OF THE
FOLLOWING:
•
ergotamine or caffeine, the active ingredients in Cafergot tablets
•
any of th
                                
                                Lugege kogu dokumenti
                                
                            

Toote omadused

                                NEW ZEALAND DATA SHEET
1
CAFERGOT (ERGOTAMINE TARTRATE 1 MG AND
CAFFEINE 100 MG TABLET)
CAFERGOT
ergotamine tartrate 1 mg and caffeine 100 mg tablet
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Ergotamine tartrate 1 mg and Caffeine 100 mg
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Cafergot tablets are round, flat with bevelled edge, 9 mm diameter,
speckled
yellow/white, inscribed with a breakline and XL on one side and plain
on the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of acute attacks of migraine with or without aura in adults.
4.2
DOSE AND METHOD OF ADMINISTRATION
Cafergot should be given at the first signs of a migraine attack.
DOSE
ADULTS
_FIRST ATTACK_
:
The first time Cafergot is taken, an initial dose of 2 Cafergot
tablets orally, is
recommended. If relief is not obtained within half an hour, a further
tablet should be
administered; this may be repeated at half-hourly intervals, but the
maximum daily dose
of 6 tablets should not be exceeded.
_ _
_SUBSEQUENT ATTACKS:_
If the pain persists, take 1 tablet every half an hour up to the
maximum daily dose of 6
tablets. The maximum weekly dose is 10 tablets. CHILDREN UNDER 18 YEARS
Not recommended.
MAXIMUM DOSE PER ATTACK OR PER DAY
Adults: 6 mg ergotamine tartrate = 6 tablets.
MAXIMUM WEEKLY DOSE
Adults: 10 mg ergotamine tartrate = 10 tablets.
SPECIAL POPULATIONS
_Renal impairment_
Cafergot is contraindicated in patients with severe renal impairment
(see
Contraindications).
_Hepatic impairment_
Cafergot is contraindicated in patients with severe hepatic impairment
(see
Contraindications). Patients with mild to moderate hepatic impairment,
especially
patients with cholestasis, should be appropriately monitored (see
Warnings and
Precautions).
_Pediatrics_
Cafergot is not recommended in children and adolescents under the age
of 18 years.
Safety and efficacy have not been established in pediatric patients.
_Geriatrics_
Cafergot is not recommended for patients aged over 65 years. No
studies have been
perfo
                                
                                Lugege kogu dokumenti
                                
                            

Vaadake dokumentide ajalugu